PRKAA2 and Obesity: Here the inhibition of the E3 ubiquitin ligase MKRN1 was sufficient to chronically activate AMPK in the liver and adipose tissues and subsequently led to systemic effects by preventing hepatic lipid accumulation and insulin resistance and promoting anti-obesity effects on diet-induced obese mice.